Drawing for DR WOLFF

USPTO serial 79382035

DR WOLFF

Reviewed by CopyMark Law Group

Status 661
Filing date
Status date
Registration date
—
Examiner
HILL, JAMES T
Law office
TMEG LAW OFFICE 101

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with DR WOLFF?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Karl M. Zielaznicki, Esq.

Karl M. Zielaznicki, Esq. Troutman Pepper Hamilton Sanders LLP600 Peachtree Street, NE, Suite 3000c/o TM DKT CLKAtlanta, GA 30308

Goods and services

ClassDescriptionStatusFirst use
003Perfumery, essential oils, cosmetics, hair lotions, dentifricesACTIVE—
005Pharmaceutical preparations, for the treatment of dermatological and gynaecological diseases and disorders; sanitary products for medical purposes, namely, sanitary preparations for medical purposes, disinfectants for sanitary purposes; dietetic supplements and dietetic preparations adapted for medical use; food for babies; material for stopping teeth; dental wax; disinfectants; preparations for destroying vermin; fungicides; herbicidesACTIVE—
010Medical apparatus and instruments, namely, menstrual cups, medical syringes, uterine syringes, vaginal syringesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 10, 2026RNWLINTERNATIONAL REGISTRATION RENEWED—
Aug 26, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 26, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 26, 2026ALIEASSIGNED TO LIE—
Aug 24, 2026ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
May 17, 2026RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jan 22, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 11, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 17, 2025RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
May 16, 2025RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
May 6, 2025RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Apr 12, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Mar 25, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 25, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Nov 5, 2024GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Nov 5, 2024GNSLLETTER OF SUSPENSION E-MAILED—
Nov 5, 2024CNSLSUSPENSION LETTER WRITTEN—
Jul 2, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 1, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 1, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 30, 2024RFNTREFUSAL PROCESSED BY IB—
Jan 2, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 2, 2024RFRRREFUSAL PROCESSED BY MPU—
Dec 21, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 20, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 15, 2023DOCKASSIGNED TO EXAMINER—
Nov 7, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 3, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 2, 2023LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Oct 26, 2023SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance